Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ResMed Inc (NYSE:RMD)

68.88
Delayed Data
As of Jul 29
 +3.18 / +4.84%
Today’s Change
48.99
Today|||52-Week Range
69.38
+28.29%
Year-to-Date
ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates
Jul 29 / Zacks.com - Paid Partner Content
ResMed (RMD) Q4 Earnings: Disappointment in the Cards?
Jul 20 / Zacks.com - Paid Partner Content
Look at Medical Product Earnings on Jul 28: BSX, RMD & More
Jul 27 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close65.70
Today’s open68.50
Day’s range68.29 - 69.38
Volume1,852,979
Average volume (3 months)890,778
Market cap$9.2B
Dividend yield1.74%
Data as of 4:02pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+3.35%
Earnings growth (this year)+2.16%
Earnings growth (next 5 years)+10.79%
Revenue growth (last year)+7.97%
P/E ratio28.2
Price/Sales4.79
Price/Book5.81

Competitors

 Today’s
change
Today’s
% change
VARVarian Medical Syste...+0.71+0.76%
TFXTeleflex Inc-0.26-0.14%
CMNCantel Medical Corp+0.65+0.98%
LIVNLivaNova PLC+0.35+0.68%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$0.67
Annual revenue (last year)$1.7B
Annual profit (last year)$352.9M
Net profit margin21.02%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Mick Farrell
President &
Chief Operating Officer
Robert Andrew Douglas
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs